Evidence map›Paper›PMID 42872213›Full record

ArticleNeurology open access2026

Advanced Brain Ageing Associated with Migraine and Post-Traumatic Headache: A Deep Learning Study.

Jay Shah, Gina Dumkrieger, Catherine D Chong, Todd J Schwedt, Teresa Wu

Abstract read
In one paragraph

Article in Neurology open access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jay ShahSchool of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, USA.
Gina DumkriegerDepartment of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Catherine D ChongASU-Mayo Center for Innovative Imaging, Tempe, AZ, USA.
Todd J SchwedtASU-Mayo Center for Innovative Imaging, Tempe, AZ, USA.
Teresa WuSchool of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, USA.

Funding

National Alzheimer's Coordinating CenterU24AG072122 · NIA · UNIVERSITY OF WASHINGTON · PI STEPHENS, KARI A · 2021 to 2025
$45.8M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Gil Dan Rabinovici · 2019 to 2026
$36.9M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI MATTHEW P FROSCH · 2019 to 2026
$36.5M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Mark W Bondi · 2019 to 2026
$34.9M
Wisconsin Alzheimer's Disease Research CenterP30AG062715 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Barbara Brigitta Bendlin · 2019 to 2026
$34.5M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2019 to 2026
$33.5M
Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Carolyn Wei Zhu · 2020 to 2026
$31.0M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER, CHRISTOPHER H VAN DYCK · 2020 to 2026
$30.2M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Miguel Arce · 2020 to 2026
$30.1M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARILYN S. ALBERT · 2020 to 2026
$29.3M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Thomas J. Grabowski · 2020 to 2026
$29.0M
NIA NIH HHS P20 AG068082NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG062422NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG062677NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG066444NIA NIH HHS P30 AG066462NIA NIH HHS P30 AG066468NIA NIH HHS P30 AG066506NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG066508NIA NIH HHS P30 AG066509NIA NIH HHS P30 AG066511NIA NIH HHS P30 AG066512NIA NIH HHS P30 AG066514NIA NIH HHS P30 AG066515NIA NIH HHS P30 AG066518NIA NIH HHS P30 AG066519NIA NIH HHS P30 AG066530NIA NIH HHS P30 AG066546NIA NIH HHS P30 AG072931NIA NIH HHS P30 AG072946NIA NIH HHS P30 AG072947NIA NIH HHS P30 AG072958NIA NIH HHS P30 AG072959NIA NIH HHS P30 AG072972NIA NIH HHS P30 AG072973NIA NIH HHS P30 AG072975NIA NIH HHS P30 AG072976NIA NIH HHS P30 AG072977NIA NIH HHS P30 AG072978NIA NIH HHS P30 AG072979NIA NIH HHS P30 AG086401NIA NIH HHS P30 AG086404NIA NIH HHS R01 AG079280NIA NIH HHS U24 AG072122NINDS NIH HHS K23 NS070891NINDS NIH HHS R61 NS113315
6 · The paper itself

Abstract

Background and Objectives: Deep learning techniques can estimate "brain age" from MRI as a proxy for brain integrity. The difference between a person's brain and chronological age (Δage) may reflect age-related structural changes. However, brain ageing in headache disorders remains poorly understood. We investigated associations between Δage and headache phenotypes and its potential for predicting headache persistence. Methods: We trained a predictive model of normal ageing using a novel ORdinal Distance Encoded Regularization (ORDER) loss and T1-weighted brain MRI scans from public datasets of healthy controls (HCs; age: 8-95 years). The model outperformed other brain-age methods on a held-out HC test set in our prior work. We then applied this model to an institutional dataset including HCs, participants with acute post-traumatic headache (APTH), persistent post-traumatic headache (PPTH) attributed to mild traumatic brain injury and migraine. The primary outcome was baseline MRI-derived Δage, and its association with headache persistence at follow-up was evaluated. Results: The study included 137 HC (39.5±12.0 years; 53% female), 99 APTH (42.2±15.3 years; 56.6% female), 49 PPTH (38.1±10.6 years; 34.7% female) and 93 migraine participants (39.6±11.7 years; 74.2% female). Baseline imaging revealed significant differences in predicted Δage across headache phenotypes (F=3.53, Discussion: Headache disorders are associated with accelerated brain ageing. Patients with primary (migraine) and secondary (PPTH) headaches exhibit accelerated brain aging and structural decline related to headache persistence compared to healthy controls. APTH participants who later developed headache persistence at 3 and 6 months had older brain signatures at baseline compared to those who recovered. Results demonstrate the potential of Δage as an early neuroimaging marker for identifying individuals at risk for PPTH. Limitations include sample size and lack of longitudinal imaging in all groups.

Identifiers

PMID42872213
PMCPMC13660858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.